The Uromigos Episode 175: Altering the Microbiome in Renal Cancer With CBM588

By The Uromigos - Last Updated: June 4, 2022

In this episode, Nazli Dizman and the Uromigos cover an update on the CBM588 probiotic strain and its phase II trial that combines the drug with ipilimumab and nivolumab to treat renal cancer. The data was presented at ASCO 2022.

Post Tags:Uromigos-ASCOUromigos-Microbiome
Did you like this article?